Uncategorized
Anti-VEGF may treat CNV due to adult-onset foveomacular vitelliform dystrophy
Intravitreal ranibizumab maintained best corrected visual acuity and diminished central macular thickness in patients with choroidal neovascularization due to adult-onset foveomacular vitelliform dystrophy, according to a study.The retrospective case series included 24 eyes that were treated with three monthly intravitreal injections of Lucentis (ranibizumab, Genentech).